Entry |
|
Symbol |
CASP3
|
Name |
|
KO |
|
Organism |
oga Otolemur garnettii (small-eared galago)
|
Pathway |
oga04650 | Natural killer cell mediated cytotoxicity |
oga04932 | Non-alcoholic fatty liver disease |
oga04933 | AGE-RAGE signaling pathway in diabetic complications |
oga05022 | Pathways of neurodegeneration - multiple diseases |
oga05163 | Human cytomegalovirus infection |
oga05167 | Kaposi sarcoma-associated herpesvirus infection |
oga05168 | Herpes simplex virus 1 infection |
oga05170 | Human immunodeficiency virus 1 infection |
|
Brite |
KEGG Orthology (KO) [BR:oga00001]
09130 Environmental Information Processing
09132 Signal transduction
04010 MAPK signaling pathway
100961435 (CASP3)
04668 TNF signaling pathway
100961435 (CASP3)
09140 Cellular Processes
09141 Transport and catabolism
04148 Efferocytosis
100961435 (CASP3)
09143 Cell growth and death
04210 Apoptosis
100961435 (CASP3)
04215 Apoptosis - multiple species
100961435 (CASP3)
04115 p53 signaling pathway
100961435 (CASP3)
09150 Organismal Systems
09151 Immune system
04623 Cytosolic DNA-sensing pathway
100961435 (CASP3)
04650 Natural killer cell mediated cytotoxicity
100961435 (CASP3)
04657 IL-17 signaling pathway
100961435 (CASP3)
09156 Nervous system
04726 Serotonergic synapse
100961435 (CASP3)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
100961435 (CASP3)
05206 MicroRNAs in cancer
100961435 (CASP3)
05205 Proteoglycans in cancer
100961435 (CASP3)
05203 Viral carcinogenesis
100961435 (CASP3)
09162 Cancer: specific types
05210 Colorectal cancer
100961435 (CASP3)
05222 Small cell lung cancer
100961435 (CASP3)
09172 Infectious disease: viral
05170 Human immunodeficiency virus 1 infection
100961435 (CASP3)
05161 Hepatitis B
100961435 (CASP3)
05160 Hepatitis C
100961435 (CASP3)
05164 Influenza A
100961435 (CASP3)
05162 Measles
100961435 (CASP3)
05168 Herpes simplex virus 1 infection
100961435 (CASP3)
05163 Human cytomegalovirus infection
100961435 (CASP3)
05167 Kaposi sarcoma-associated herpesvirus infection
100961435 (CASP3)
05169 Epstein-Barr virus infection
100961435 (CASP3)
05165 Human papillomavirus infection
100961435 (CASP3)
09171 Infectious disease: bacterial
05132 Salmonella infection
100961435 (CASP3)
05133 Pertussis
100961435 (CASP3)
05134 Legionellosis
100961435 (CASP3)
05152 Tuberculosis
100961435 (CASP3)
09174 Infectious disease: parasitic
05146 Amoebiasis
100961435 (CASP3)
05145 Toxoplasmosis
100961435 (CASP3)
09164 Neurodegenerative disease
05010 Alzheimer disease
100961435 (CASP3)
05012 Parkinson disease
100961435 (CASP3)
05014 Amyotrophic lateral sclerosis
100961435 (CASP3)
05016 Huntington disease
100961435 (CASP3)
05020 Prion disease
100961435 (CASP3)
05022 Pathways of neurodegeneration - multiple diseases
100961435 (CASP3)
09166 Cardiovascular disease
05417 Lipid and atherosclerosis
100961435 (CASP3)
05416 Viral myocarditis
100961435 (CASP3)
09167 Endocrine and metabolic disease
04936 Alcoholic liver disease
100961435 (CASP3)
04932 Non-alcoholic fatty liver disease
100961435 (CASP3)
04933 AGE-RAGE signaling pathway in diabetic complications
100961435 (CASP3)
09176 Drug resistance: antineoplastic
01524 Platinum drug resistance
100961435 (CASP3)
09180 Brite Hierarchies
09181 Protein families: metabolism
01002 Peptidases and inhibitors [BR:oga01002]
100961435 (CASP3)
Enzymes [BR:oga01000]
3. Hydrolases
3.4 Acting on peptide bonds (peptidases)
3.4.22 Cysteine endopeptidases
3.4.22.56 caspase-3
100961435 (CASP3)
Peptidases and inhibitors [BR:oga01002]
Cysteine peptidases
Family C14: caspase family
100961435 (CASP3)
|
SSDB |
|
Motif |
|
Other DBs |
|
LinkDB |
|
Position |
Unknown
|
AA seq |
277 aa
MENTENSVDSKSIKNLETKIIHGSKSMDSGISLDTRYKMDYPEMGLCIIINNKNFHESTG
MPPRSGTDVDAANLRETFMNLKYEVRNKNDLTCEEIVAFMRNVSKEDHSKRSSFVCVILS
HGEEGIIFGTNGPVDLKKITSFFRGDYCRSLTGKPKLFIIQACRGTELDCGIETDSGTED
DMACQKIPVEADFLYAYSTAPGYYSWRNSKDGSWFIQSLCAMLKLYAHKLEFMHILTRVN
RKVATEFESFSFDSTFHAKKQIPCIVSMLTKDLYFYH |
NT seq |
834 nt +upstreamnt +downstreamnt
atggagaatactgaaaactcagtggattcaaaatctattaaaaatttggaaacaaagatc
atccatggaagcaaatcaatggactctggaatatccttggacactagatataaaatggat
tatcctgaaatgggtttatgtataataattaataataagaactttcacgaaagtacagga
atgccacctcggtcaggcacagatgtagatgcagcaaacctcagggaaacattcatgaac
ttgaaatacgaagtcaggaataaaaatgatcttacatgtgaagaaattgtggcattcatg
cgcaatgtttctaaagaagatcatagcaaaaggagcagttttgtctgtgtaattctgagc
catggtgaagaaggaataatttttgggacaaatggacctgttgacctgaaaaaaataaca
agtttcttcagaggggattattgtagaagtctaactggaaaacccaaacttttcattatt
caggcctgccgaggtacagaactggactgtggcattgagacggacagtggtactgaggat
gacatggcgtgtcagaaaatacccgtggaggctgacttcctgtatgcgtactccacagca
cctggttactattcctggcgaaactcaaaggatggctcctggttcatccagtcgctttgc
gccatgctgaaactgtacgctcacaagctcgagtttatgcacattctcacccgggtgaac
cgaaaggtggcaacagaatttgaatccttttcctttgactctacttttcatgcaaagaaa
cagattccatgtattgtgtccatgctcacaaaagacctgtatttttatcactaa |